RADEMIKIBART
UNII NWV8DWU7QM

Substance Identification & Data

This profile provides standardized clinical and technical data for Rademikibart, uniquely identified by the FDA Unique Ingredient Identifier (UNII) NWV8DWU7QM.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2648260-80-2 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

NWV8DWU7QM

CAS Registry Number

2648260-80-2

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

RADEMIKIBART

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C199098

National Cancer Institute reference terminology for clinical and research data.

INN ID

12401

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Rademikibart. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

RADEMIKIBART

Common Names & Synonyms

IMMUNOGLOBULIN G4 (223-PROLINE,DE-C-TERMINAL-LYSINE), ANTI-(HUMAN INTERLEUKIN 4 RECEPTOR SUBUNIT .ALPHA.) (HUMAN MONOCLONAL CBP-201 .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL CBP-201 .KAPPA.-CHAIN, DIMER

IMMUNOGLOBULIN G4-KAPPA, ANTI-(HOMO SAPIENS IL4R (INTERLEUKIN 4 RECEPTOR, IL4RA, IL-4RA, INTERLEUKIN 13 RECEPTOR, CD124)), HOMO SAPIENS MONOCLONAL ANTIBODY (GAMMA4 HEAVY CHAIN HOMO SAPIENS (1-441) (VH (HOMO SAPIENS IGHV3-23*04 (88.8%) -(IGHD) -IGHJ4*01 (100%), CDR-IMGT (8.7.9) (26-33.51-57.96-104)) (1-115)-HOMO SAPIENS IGHG4*01, NG4M(A) CH2 L92, G4V5 H P10 (CH1 (116-213), HINGE 1-12 S10>P (223) (214-225), CH2 L92 (304) (226-335), CH3 (336-440), CHS K2>DEL (441)) (116-441)), (129-216')-DISULFIDE WITH KAPPA LIGHT CHAIN HOMO SAPIENS (1'-216') (V-KAPPA (HOMO SAPIENS IGKV3-20*01 (97.9%) -IGKJ1*01 (100%), CDR-IMGT (7.3.10) (27-33.51-53.90-99)) (1'-109') -HOMO SAPIENS IGKC*01 (100%), KM3 A45.1 (155), V101 (193) (110'- 216')); DIMER (221-221'':224-224'')-BISDISULFIDE, PRODUCED IN CHINESE HAMSTER OVARY (CHO) CELLS, GLYCOFORM ALFA ANTI-INFLAMMATORY)

RADEMIKIBART [INN]

RADEMIKIBART [WHO-DD]

External Clinical & Regulatory Resources

Previous UNIINWU4UN7SMJ

Next UNIINWW345VUM2